There is a flurry of activity involving Danaher Corporation (DHR). Rosen Law Firm has initiated an investigation for potential breaches of fiduciary duty by Danaher, accompanied by a separate investigation by Kahn Swick & Foti, LLC. Despite this, many organizations increased their investments, including Cove Private Wealth LLC, ST Germain D J Co. Inc., Banque Pictet & Cie SA, and IMS Capital Management. In contrast, several entities, such as TD Private Client Wealth LLC, Beacon Investment Advisory Services Inc., and BigSur Wealth Management LLC, have decreased their positions.
The corporation is set to release key financial updates in 2025's Q3 earnings call on October 21. Amid these developments, Wells Fargo has maintained its ‘Equal Weight’ rating but reduced PT on DHR to $205.
Other news related to DHR includes the launch of Alt-R HDR Enhancer Protein, reinforcing its foothold in precision medicine. Despite challenges in China, the company has seen diagnostics growth.
Finally, multiple analysts have shared mixed opinions about DHR stock. While some mark it as ‘Fool's Gold,’ others have increased or initiated new investments.
Danaher Corporation DHR News Analytics from Wed, 25 Jun 2025 07:00:00 GMT to Sat, 27 Sep 2025 21:01:06 GMT - Innovation 6 - Information 7 - Rumor 2
